PharVision Advisers’s Signet Jewelers SIG Stock Holding History

PharVision Advisers’s Portfolio SIG Stock Details SIG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,307	Closed	-$263K	–	780
2025 Q2	$263K	Buy	+3,307	New	+$220K	0.38%	115

Other funds holding SIG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PharVision Advisers's SIG Position: Q3 2025 in Review

PharVision Advisers sold out of Signet Jewelers (SIG) in Q3 2025, closing a stake of 3,307 shares — an estimated $263K sold.

PharVision Advisers first reported a position in SIG in Q2 2025 and held it in 1 quarter. The position peaked at $263K in Q2 2025. 318 funds tracked by Wall St. Rank hold SIG as of Q3 2025.

PharVision Advisers reported no remaining Signet Jewelers position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 3,307 Signet Jewelers shares in Q3 2025, an estimated $263K.
PharVision Advisers first reported a position in Signet Jewelers in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Signet Jewelers position peaked at $263K in Q2 2025.
318 funds tracked by Wall St. Rank held Signet Jewelers as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.